Government-funded Hong Kong Startup Looks To Run Traditional Chinese Medicine Treatment For IBS Through Clinical Trials
This article was originally published in PharmAsia News
Executive Summary
HONG KONG - Developing a treatment for irritable bowel syndrome has proven to be an elusive goal and there is no product available in Asia to fully treat the disease, but a government-funded Hong Kong startup hopes a traditional Chinese medicine can stand the rigors of pharmaceutical approvals and fill an unmet medical need